# Therapeutic Advances in Chronic Disease Nonalcoholic fatty liver disease and health outcomes: An umbrella review of systematic reviews and meta-analyses

CorpusID: 248931568 - [https://www.semanticscholar.org/paper/bf988e713b6290674803e0d2001ae3ae5ff20527](https://www.semanticscholar.org/paper/bf988e713b6290674803e0d2001ae3ae5ff20527)

Fields: Medicine

## (s13) Moderate:
Number of References: 9

(p13.0) >1 non-critical weakness. The systematic review has more than one weakness, but no critical flaws. It may provide an accurate summary of the results of the available studies that were included in the review. Low: 1 critical flaw with or without non-critical weaknesses. The review has a critical flaw and may not provide an accurate and comprehensive summary of the available studies that address the question of interest. Critically low: >1 critical flaw with or without non-critical weaknesses. The review has more than one critical flaw and should not be relied on to provide an accurate and comprehensive summary of the available studies. No 2,4,7,9,11,13, and 15 are the critical items. Table 2.

(p13.1) (Continued) journals.sagepub.com/home/taj 17 structure were also damaged by NAFLD. We demonstrated the association between NAFLD and peak A velocity and LVEDD was both graded as high. In NAFLD patients, the role of proinflammatory cytokines, insulin resistance, and dyslipidemia acts together on the cardiac metabolism and function, [86][87][88] which directly causes the impairment on the heart.
